Earnings call transcript: Kemira Q1 2026 earnings miss, stock slides 7%

Kemira reported Q1 2026 EPS of EUR 0.29, missing the roughly EUR 0.32 forecast, while revenue fell EUR 32 million year over year and the stock dropped 7.01%. The company cited weak demand, a EUR 26 million currency headwind, and rising raw material and logistics costs tied to geopolitical tensions, though it kept full-year revenue guidance of EUR 2.6 billion-EUR 3.0 billion and EBITDA guidance of EUR 470 million-EUR 570 million. Management also announced faster cost cuts, including plans to reduce about 150 roles, while continuing acquisitions, facility expansion, and buybacks.

Analysis

The market is treating this as a classic earnings miss, but the more important signal is that the company is now fighting a margin war on two fronts: weaker end-demand and a lagged pass-through of input inflation. That combination usually creates a “trough-before-recovery” setup, but only if pricing actions hold and demand doesn’t deteriorate further into Q2/Q3. The fact that management is still guiding the year and starting restructuring at the same time suggests the P&L risk is front-loaded, while any benefit from cost actions and price increases should begin to show over the next 1-2 quarters.

The bigger second-order issue is mix. The weak spot is not just cyclical volume softness; APAC weakness in packaging looks increasingly structural, which means a lower terminal margin profile unless there is actual footprint rationalization. That matters because it changes the valuation debate from “temporary margin compression” to “earnings quality reset,” and it also shifts incremental capital toward the more defensible water platform and away from packaging where pricing power is likely eroding.

On the other side of the ledger, this is one of the few industrials with enough balance-sheet flexibility to keep buying growth and returning cash while cutting costs. That creates a self-help floor, but it also means the stock can stay cheap if the market sees buybacks and M&A as defensive rather than accretive. The contrarian view is that the selloff may be overdone on the headline miss alone; the real catalyst is whether Q2 shows pricing inflection and whether restructuring delivers visible run-rate savings by mid-year. If those don’t materialize, the stock deserves to de-rate further because the market will start discounting a lower-through-cycle EBITDA margin.

Key Decisions for Investors

• Avoid chasing the post-earnings bounce; wait 4-6 weeks for Q2 pricing and volume data before building a long. Better entry is only if the stock stabilizes while management demonstrates pass-through and no further demand deterioration.
• Relative-value long water-exposed industrials with stronger pricing power versus APADU if you want to stay in the space; Kemira’s packaging weakness makes it a lower-quality earnings stream until APAC normalizes. Use a 3-6 month horizon.
• For event-driven accounts, consider selling out-of-the-money puts 1-2 quarters out to express a constructive but cautious view. The setup offers income if the stock grinds sideways while restructuring and price increases work through.
• If APADU rallies back to pre-miss levels without evidence of margin recovery, fade the move with a tactical short or a call spread hedge; the risk/reward is poor until the market sees proof of 2H margin repair.
• Pair trade idea: long a higher-quality water infrastructure / treatment name, short APADU, targeting 6-12 months. The thesis is that water names with cleaner pricing and less APAC exposure should outperform if industrial demand stays soft.